Global Alliance For TB Drug Development Appoints Veteran Pharmaceutical Executive as New Chief Executive

NEW YORK--(BUSINESS WIRE)--The Global Alliance for TB Drug Development (TB Alliance), a not-for-profit product development partnership accelerating the discovery and development of new drugs to fight tuberculosis (TB), today announced the appointment of Dr. Jerome Premmereur as President and Chief Executive Officer.

MORE ON THIS TOPIC